QiC Hepatitis C results announced

The first Quality in Care (QiC) Hepatitis C awards event took place last week recognising good practice in hepatitis C care.

NHS Tayside won Best treatment pathway initiative at QiC Hepatitis C

Held September 16 at the British Association for the Study of the Liver (BASL) conference in Gateshead QiC Hepatitis C celebrated the work of eight projects working to improve the lives of people with hepatitis C.

Categories included hepatitis C prevention, diagnosis & testing, treatment pathways and patient support in the UK.

Winners included NHS Tayside for its work providing access to hepatitis C treatment for people who inject drugs and Dundee CHP for its work to improve outcomes for patients with blood borne virus in Dundee.

Comments from judges on the NHS Tayside project included: “It is a cost-effective initiative with a patient-centred approach providing persuasive evidence that people who inject drugs can have similar or better treatment outcomes than people who do not inject drugs – much needed in the face of widespread resistance to treating this group of patients.”

High commendations went to Dorset Viral Hepatitis Service and the Addaction programme in Cornwall.

The QiC Hepatitis C programme is funded by Bristol-Myers Squibb and Gilead and supported by BASL, British Liver Trust, The Hepatitis C Trust and Liver4Life.

See the full results of QiC Hepatitis C 2014

See the gallery of the awards evening 2014



Author: Tom Meek

Programmes

Tags

  • KEY DATES FOR 2018 TO BE ANNOUNCED
QiC Hepatitis C is supported by: